Cited by 191Intensive Care Unit Cognitive DisordersSepsis Diagnosis and TreatmentBacterial Infections and Vaccines

Cerebral dysfunctions caused by sepsis during ageing

Open access
Manabe, Tatsuya, Heneka, Michael T.·2022·Nature Reviews Immunology

Abstract

Systemic inflammation elicited by sepsis can induce an acute cerebral dysfunction known as sepsis-associated encephalopathy (SAE). Recent evidence suggests that SAE is common but shows a dynamic trajectory over time. Half of all patients with sepsis develop SAE in the intensive care unit, and some survivors present with sustained cognitive impairments for several years after initial sepsis onset. It is not clear why some, but not all, patients develop SAE and also the factors that determine the persistence of SAE. Here, we first summarize the chronic pathology and the dynamic changes in cognitive functions seen after the onset of sepsis. We then outline the cerebral effects of sepsis, such as neuroinflammation, alterations in neuronal synapses and neurovascular changes. We discuss the key factors that might contribute to the development and persistence of SAE in older patients, including premorbid neurodegenerative pathology, side effects of sedatives, renal dysfunction and latent virus reactivation. Finally, we postulate that some of the mechanisms that underpin neuropathology in SAE may also be relevant to delirium and persisting cognitive impairments that are seen in patients with severe COVID-19.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41577-021-00643-7

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Bacterial sepsis is linked to systemic inflammation, mainly through LPS engagement with Toll-like receptors (TLR), which may result in acute brain dysfunction, particularly in older patients.

    “Bacterial sepsis is linked to systemic inflammation, mainly through LPS engagement with Toll-like receptors (TLR), which may result in acute brain dysfunction, particularly in older patients [100].”

    From What would it take to prove that a chronic infection is a causal agent in Alzheimer’s disease? (2025) · cites this paper as [100]

    The ‘Acute phase of sepsis’ section describes inflammation through innate immune receptors, and ‘Immediate neuroinflammation’ says circulating LPS can activate TLR2 and TLR4, contributing to brain inflammation. The paper also reports acute cerebral dysfunction after sepsis and heightened responses with ageing. It does not establish that LPS–TLR engagement is the main route of systemic inflammation; it describes other triggers and pathways as well. Page numbers were not available in our copy. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 237 · Cited by 191

Research works printed but not linked: 181

  1. [1]Singer M The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) JAMA 2016 315 801 810 26903338 PMC4968574
  2. [2]Rudd KE Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study Lancet 2020 395 200 211 31954465 PMC6970225
  3. [3]Ljungström L Andersson R Jacobsson G Incidences of community onset severe sepsis, Sepsis-3 sepsis, and bacteremia in Sweden — a prospective population-based study PLoS ONE 2019 14 e0225700 31805110 PMC6894792
  4. [5]Yende S Long-term host immune response trajectories among hospitalized patients with sepsis JAMA Netw. Open 2019 2 e198686 31390038 PMC6686981
  5. [7]Eidelman LA Putterman D Putterman C Sprung CL The spectrum of septic encephalopathy: definitions, etiologies, and mortalities JAMA 1996 275 470 473 8627969
  6. [8]Sonneville R Potentially modifiable factors contributing to sepsis-associated encephalopathy Intensive Care Med. 2017 43 1075 1084 28466149
  7. [9]Inouye SK Postoperative delirium in older adults: best practice statement from the American Geriatrics Society J. Am. Coll. Surg. 2015 220 136 148.e1 25535170
  8. [10]Widmann CN Heneka MT Long-term cerebral consequences of sepsis Lancet Neurol. 2014 13 630 636 24849863
  9. [11]Fritze T Doblhammer G Widmann CN Heneka MT Time course of dementia following sepsis in German health claims data Neurol. Neuroimmunol. Neuroinflamm. 2021 8 e911 33293458 PMC7803331
  10. [12]Heneka MT Golenbock DT Latz E Innate immunity in Alzheimer’s disease Nat. Immunol. 2015 16 229 236 25689443
  11. [13]Fletcher JM Lalor SJ Sweeney CM Tubridy N Mills KHG T cells in multiple sclerosis and experimental autoimmune encephalomyelitis Clin. Exp. Immunol. 2010 162 1 11 20682002 PMC2990924
  12. [15]Vincent J-L Prevalence and outcomes of infection among patients in intensive care units in 2017 JAMA 2020 323 1478 1487 32207816 PMC7093816
  13. [16]Ranzani OT New sepsis definition (Sepsis-3) and community-acquired pneumonia mortality. A validation and clinical decision-making study Am. J. Respir. Crit. Care Med. 2017 196 1287 1297 28613918
  14. [17]Jain S Community-acquired pneumonia requiring hospitalization among U.S. adults N. Engl. J. Med. 2015 373 415 427 26172429 PMC4728150
  15. [18]Southeast Asia Infectious Disease Clinical Research Network Causes and outcomes of sepsis in Southeast Asia: a multinational multicentre cross-sectional study Lancet Glob. Health 2017 5 e157 e167 28104185 PMC5332551
  16. [19]Hotchkiss RS Sepsis and septic shock Nat. Rev. Dis. Prim. 2016 2 16045 28117397 PMC5538252
  17. [21]Stortz JA Benchmarking clinical outcomes and the immunocatabolic phenotype of chronic critical illness after sepsis in surgical intensive care unit patients J. Trauma. Acute Care Surg. 2018 84 342 349 29251709 PMC5780256
  18. [22]Gentile LF Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care J. Trauma. Acute Care Surg. 2012 72 1491 1501 22695412 PMC3705923
  19. [23]Prescott HC Langa KM Iwashyna TJ Readmission diagnoses after hospitalization for severe sepsis and other acute medical conditions JAMA 2015 313 1055 1057 25756444 PMC4760618
  20. [24]Hotchkiss RS Coopersmith CM McDunn JE Ferguson TA Tilting toward immunosuppression Nat. Med. 2009 15 496 497 19424209 PMC3786779
  21. [25]Walton AH Reactivation of multiple viruses in patients with sepsis PLoS ONE 2014 9 e98819 24919177 PMC4053360
  22. [26]Yang Y Mitochondrial DNA haplogroup R in the Han population and recovery from septic encephalopathy Intensive Care Med. 2011 37 1613 1619 21847652
  23. [27]Muzambi R Assessment of common infections and incident dementia using UK primary and secondary care data: a historical cohort study Lancet Healthy Longev. 2021 2 e426 e435 34240064 PMC8245326
  24. [30]Hosokawa K Clinical neurophysiological assessment of sepsis-associated brain dysfunction: a systematic review Crit. Care 2014 18 674 25482125 PMC4277650
  25. [31]Ehler J The prognostic value of neurofilament levels in patients with sepsis-associated encephalopathy — a prospective, pilot observational study PLoS ONE 2019 14 e0211184 30677080 PMC6345472
  26. [32]Mattsson N Cullen NC Andreasson U Zetterberg H Blennow K Association between longitudinal plasma neurofilament light and neurodegeneration in patients with Alzheimer disease JAMA Neurol. 2019 76 791 799 31009028 PMC6583067
  27. [33]Mielke MM Plasma and CSF neurofilament light: relation to longitudinal neuroimaging and cognitive measures Neurology 2019 93 e252 e260 31182505 PMC6656645
  28. [34]Nguyen DN Elevated serum levels of S-100β protein and neuron-specific enolase are associated with brain injury in patients with severe sepsis and septic shock Crit. Care Med. 2006 34 1967 1974 16607230
  29. [35]Semmler A Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors J. Neurol. Neurosurg. Psychiatry 2013 84 62 69 23134661
  30. [36]Andonegui G Targeting inflammatory monocytes in sepsis-associated encephalopathy and long-term cognitive impairment JCI Insight 2018 3 e99364 PMC6012517 29720578
  31. [37]Gunther ML The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study Crit. Care Med. 2012 40 2022 2032 22710202 PMC3697780
  32. [38]Orhun G Brain volume changes in patients with acute brain dysfunction due to sepsis Neurocrit. Care 2020 32 459 468 31187433
  33. [40]Sharshar T The neuropathology of septic shock Brain Pathol. 2004 14 21 33 14997934 PMC8095740
  34. [41]Lee JW Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of β-amyloid generation J. Neuroinflammation 2008 5 37 18759972 PMC2556656
  35. [42]Semmler A Sepsis causes neuroinflammation and concomitant decrease of cerebral metabolism J. Neuroinflammation 2008 5 38 18793399 PMC2553764
  36. [43]Laflamme N Echchannaoui H Landmann R Rivest S Cooperation between Toll-like receptor 2 and 4 in the brain of mice challenged with cell wall components derived from Gram-negative and Gram-positive bacteria Eur. J. Immunol. 2003 33 1127 1138 12672079
  37. [44]Laflamme N Rivest S Toll-like receptor 4: the missing link of the cerebral innate immune response triggered by circulating Gram-negative bacterial cell wall components FASEB J. 2001 15 155 163 11149903
  38. [47]Banks WA Kastin AJ Gutierrez EG Penetration of interleukin-6 across the murine blood–brain barrier Neurosci. Lett. 1994 179 53 56 7845624
  39. [48]Gutierrez EG Banks WA Kastin AJ Murine tumor necrosis factor α is transported from blood to brain in the mouse J. Neuroimmunol. 1993 47 169 176 8370768
  40. [49]Liu X Cell-type-specific interleukin 1 receptor 1 signaling in the brain regulates distinct neuroimmune activities Immunity 2019 50 317 333.e6 30683620 PMC6759085
  41. [52]Skelly DT Hennessy E Dansereau M-A Cunningham C A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1β, TNF-α and IL-6 challenges in C57BL/6 mice PLoS One 2013 8 e69123 23840908 PMC3698075
  42. [54]Gu Y Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme Science 1997 275 206 209 8999548
  43. [55]Ghayur T Caspase-1 processes IFN-γ-inducing factor and regulates LPS-induced IFN-γ production Nature 1997 386 619 623 9121587
  44. [56]Ruffoli R The chemical neuroanatomy of vagus nerve stimulation J. Chem. Neuroanat. 2011 42 288 296 21167932
  45. [57]Layé S Subdiaphragmatic vagotomy blocks induction of IL-1β mRNA in mice brain in response to peripheral LPS Am. J. Physiol. 1995 268 R1327 R1331 7771597
  46. [58]Hansen MK Taishi P Chen Z Krueger JM Vagotomy blocks the induction of interleukin-1β (IL-1β) mRNA in the brain of rats in response to systemic IL-1β J. Neurosci. 1998 18 2247 2253 9482809 PMC6792909
  47. [60]Hosoi T Okuma Y Nomura Y Electrical stimulation of afferent vagus nerve induces IL-1β expression in the brain and activates HPA axis Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000 279 R141 R147 10896875
  48. [61]Roosevelt RW Smith DC Clough RW Jensen RA Browning RA Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat Brain Res. 2006 1119 124 132 16962076 PMC1751174
  49. [62]Odoj K In vivo mechanisms of cortical network dysfunction induced by systemic inflammation Brain Behav. Immun. 2021 96 113 126 34052361
  50. [64]Yamamoto M Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway Science 2003 301 640 643 12855817
  51. [65]Gitlin L Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus Proc. Natl Acad. Sci. USA 2006 103 8459 8464 16714379 PMC1464000
  52. [66]Kato H Cell type-specific involvement of RIG-I in antiviral response Immunity 2005 23 19 28 16039576
  53. [68]Yamato M Brain interleukin-1β and the intrinsic receptor antagonist control peripheral Toll-like receptor 3-mediated suppression of spontaneous activity in rats PLoS ONE 2014 9 e90950 24621600 PMC3951245
  54. [69]Murray C Interdependent and independent roles of type I interferons and IL-6 in innate immune, neuroinflammatory and sickness behaviour responses to systemic poly I:C Brain Behav. Immun. 2015 48 274 286 25900439 PMC4521083
  55. [70]Fortier M-E The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004 287 R759 R766 15205185
  56. [71]McGarry N Double stranded RNA drives anti-viral innate immune responses, sickness behavior and cognitive dysfunction dependent on dsRNA length, IFNAR1 expression and age Brain Behav. Immun. 2021 95 413 428 33892139 PMC8447494
  57. [72]Lemstra AW Microglia activation in sepsis: a case–control study J. Neuroinflammation 2007 4 4 17224051 PMC1783646
  58. [73]Zrzavy T Pro-inflammatory activation of microglia in the brain of patients with sepsis Neuropathol. Appl. Neurobiol. 2019 45 278 290 29804289 PMC6487964
  59. [75]Chang C-W GMP-compliant fully automated radiosynthesis of [18F]FEPPA for PET/MRI imaging of regional brain TSPO expression EJNMMI Res. 2021 11 26 33725191 PMC7966678
  60. [76]Yirmiya R Goshen I Immune modulation of learning, memory, neural plasticity and neurogenesis Brain Behav. Immun. 2011 25 181 213 20970492
  61. [77]Satizabal CL Zhu YC Mazoyer B Dufouil C Tzourio C Circulating IL-6 and CRP are associated with MRI findings in the elderly: the 3C-Dijon study Neurology 2012 78 720 727 22357713
  62. [78]Singh-Manoux A Interleukin-6 and C-reactive protein as predictors of cognitive decline in late midlife Neurology 2014 83 486 493 24991031 PMC4141998
  63. [80]van den Boogaard M Endotoxemia-induced inflammation and the effect on the human brain Crit. Care 2010 14 R81 R81 20444270 PMC2911704
  64. [81]Krabbe KS Low-dose endotoxemia and human neuropsychological functions Brain Behav. Immun. 2005 19 453 460 15963684
  65. [84]Wu L The dynamic change of serum S100B levels from day 1 to day 3 is more associated with sepsis-associated encephalopathy Sci. Rep. 2020 10 7718 32382007 PMC7206038
  66. [86]van Munster BC Time-course of cytokines during delirium in elderly patients with hip fractures J. Am. Geriatr. Soc. 2008 56 1704 1709 18691278
  67. [87]Serantes R Interleukin-1β enhances GABAA receptor cell-surface expression by a phosphatidylinositol 3-kinase/Akt pathway: relevance to sepsis-associated encephalopathy J. Biol. Chem. 2006 281 14632 14643 16567807
  68. [88]Cape E Cerebrospinal fluid markers of neuroinflammation in delirium: a role for interleukin-1β in delirium after hip fracture J. Psychosom. Res. 2014 77 219 225 25124807 PMC4274366
  69. [89]Sparkman NL Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers J. Neurosci. 2006 26 10709 10716 17050710 PMC6674759
  70. [90]Terrando N The impact of IL-1 modulation on the development of lipopolysaccharide-induced cognitive dysfunction Crit. Care 2010 14 R88 20470406 PMC2911722
  71. [91]Skelly DT Acute transient cognitive dysfunction and acute brain injury induced by systemic inflammation occur by dissociable IL-1-dependent mechanisms Mol. Psychiatry 2019 24 1533 1548 29875474 PMC6510649
  72. [92]Terry RD Physical basis of cognitive alterations in alzheimer’s disease: synapse loss is the major correlate of cognitive impairment Ann. Neurol. 1991 30 572 580 1789684
  73. [93]Scheff SW Price DA Schmitt FA DeKosky ST Mufson EJ Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment Neurology 2007 68 1501 1508 17470753
  74. [94]Robinson JL Perforant path synaptic loss correlates with cognitive impairment and Alzheimer’s disease in the oldest-old Brain 2014 137 2578 2587 25012223 PMC4132652
  75. [96]Dumitriu D Selective changes in thin spine density and morphology in monkey prefrontal cortex correlate with aging-related cognitive impairment J. Neurosci. 2010 30 7507 7515 20519525 PMC2892969
  76. [98]Weberpals M NOS2 gene deficiency protects from sepsis-induced long-term cognitive deficits J. Neurosci. 2009 29 14177 14184 19906966 PMC6665081
  77. [99]Beyer MMS Enduring changes in neuronal function upon systemic inflammation are NLRP3 inflammasome dependent J. Neurosci. 2020 40 5480 5494 32499379 PMC7343321
  78. [101]Garré JM Silva HM Lafaille JJ Yang G CX3CR1+ monocytes modulate learning and learning-dependent dendritic spine remodeling via TNF-α Nat. Med. 2017 23 714 722 28504723 PMC5590232
  79. [102]Manabe T Systemic inflammation induced the delayed reduction of excitatory synapses in the CA3 during ageing J. Neurochem. 2021 159 525 542 34379806
  80. [103]Weinhard L Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction Nat. Commun. 2018 9 1228 29581545 PMC5964317
  81. [104]Miyamoto A Microglia contact induces synapse formation in developing somatosensory cortex Nat. Commun. 2016 7 12540 27558646 PMC5007295
  82. [105]Akiyoshi R Microglia enhance synapse activity to promote local network synchronization eNeuro 2018 5 ENEURO.0088-18.2018 30406198 PMC6220592
  83. [106]Peters van Ton AM Verbeek MM Alkema W Pickkers P Abdo WF Downregulation of synapse-associated protein expression and loss of homeostatic microglial control in cerebrospinal fluid of infectious patients with delirium and patients with Alzheimer’s disease Brain Behav. Immun. 2020 89 656 667 32592865
  84. [108]Finnema SJ Imaging synaptic density in the living human brain Sci. Transl. Med. 2016 8 348ra96 348ra96 27440727
  85. [109]Ehler J Translational evidence for two distinct patterns of neuroaxonal injury in sepsis: a longitudinal, prospective translational study Crit. Care 2017 21 262 29058589 PMC5653470
  86. [112]Flierl MA Inhibition of complement C5a prevents breakdown of the blood–brain barrier and pituitary dysfunction in experimental sepsis Crit. Care 2009 13 R12 19196477 PMC2688129
  87. [113]Singer BH Cecal ligation and puncture results in long-term central nervous system myeloid inflammation PLoS ONE 2016 11 e0149136 26862765 PMC4749127
  88. [114]Chelazzi C Villa G Mancinelli P De Gaudio AR Adembri C Glycocalyx and sepsis-induced alterations in vascular permeability Crit. Care 2015 19 26 25887223 PMC4308932
  89. [116]Hippensteel JA Circulating heparan sulfate fragments mediate septic cognitive dysfunction J. Clin. Invest. 2019 129 1779 1784 30720464 PMC6436867
  90. [117]Tejera D Systemic inflammation impairs microglial Aβ clearance through NLRP3 inflammasome EMBO J. 2019 38 e101064 31359456 PMC6717897
  91. [118]Garré JM Yang G Contributions of monocytes to nervous system disorders J. Mol. Med. 2018 96 873 883 30030568 PMC6186399
  92. [119]Jafari M Phagocyte-mediated synapse removal in cortical neuroinflammation is promoted by local calcium accumulation Nat. Neurosci. 2021 24 355 367 33495636
  93. [120]van der Poll T van de Veerdonk FL Scicluna BP Netea MG The immunopathology of sepsis and potential therapeutic targets Nat. Rev. Immunol. 2017 17 407 420 28436424
  94. [121]Jacob A Hensley LK Safratowich BD Quigg RJ Alexander JJ The role of the complement cascade in endotoxin-induced septic encephalopathy Lab. Invest. 2007 87 1186 1194 17922019
  95. [122]Bodea L-G Neurodegeneration by activation of the microglial complement–phagosome pathway J. Neurosci. 2014 34 8546 8556 24948809 PMC6608212
  96. [124]Shoji H Takao K Hattori S Miyakawa T Age-related changes in behavior in C57BL/6J mice from young adulthood to middle age Mol. Brain 2016 9 11 26822304 PMC4730600
  97. [125]Li S A complement-microglial axis driving inhibitory synapse related protein loss might contribute to systemic inflammation-induced cognitive impairment Int. Immunopharmacol. 2020 87 106814 32707491
  98. [126]Stevens B The classical complement cascade mediates CNS synapse elimination Cell 2007 131 1164 1178 18083105
  99. [129]Scott-Hewitt N Local externalization of phosphatidylserine mediates developmental synaptic pruning by microglia EMBO J. 2020 39 e105380 32657463 PMC7429741
  100. [130]Litvinchuk A Complement C3aR inactivation attenuates tau pathology and reverses an immune network deregulated in tauopathy models and Alzheimer’s disease Neuron 2018 100 1337 1353.e5 30415998 PMC6309202
  101. [131]Filipello F The microglial innate immune receptor TREM2 is required for synapse elimination and normal brain connectivity Immunity 2018 48 979 991.e8 29752066
  102. [132]Li T A splicing isoform of GPR56 mediates microglial synaptic refinement via phosphatidylserine binding EMBO J. 2020 39 e104136 32452062 PMC7429740
  103. [133]Brown GC Neher JJ Microglial phagocytosis of live neurons Nat. Rev. Neurosci. 2014 15 209 216 24646669
  104. [135]Youm Y-H Canonical Nlrp3 inflammasome links systemic low-grade inflammation to functional decline in aging Cell Metab. 2013 18 519 532 24093676 PMC4017327
  105. [137]Keane L mTOR-dependent translation amplifies microglia priming in aging mice J. Clin. Invest. 2021 131 132727 33108356 PMC7773382
  106. [138]Matt SM Lawson MA Johnson RW Aging and peripheral lipopolysaccharide can modulate epigenetic regulators and decrease IL-1β promoter DNA methylation in microglia Neurobiol. Aging 2016 47 1 9 27500965 PMC5075520
  107. [139]Chen J Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system Brain Behav. Immun. 2008 22 301 311 17951027 PMC2374919
  108. [141]Harrison JK Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia Proc. Natl Acad. Sci. USA 1998 95 10896 10901 9724801 PMC27992
  109. [142]Chapman GA Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage J. Neurosci. 2000 20 RC87 10899174 PMC6772533
  110. [146]Collar AL The homozygous CX3CR1-M280 mutation impairs human monocyte survival JCI Insight 2018 3 95417 29415879 PMC5821174
  111. [147]Ishizuka K Rare genetic variants in CX3CR1 and their contribution to the increased risk of schizophrenia and autism spectrum disorders Transl. Psychiatry 2017 7 e1184 28763059 PMC5611740
  112. [148]Bateman RJ Clinical and biomarker changes in dominantly inherited Alzheimer’s disease N. Engl. J. Med. 2012 367 795 804 22784036 PMC3474597
  113. [149]Savva GM Age, neuropathology, and dementia N. Engl. J. Med. 2009 360 2302 2309 19474427
  114. [150]Lopez-Rodriguez AB Acute systemic inflammation exacerbates neuroinflammation in Alzheimer’s disease: IL-1β drives amplified responses in primed astrocytes and neuronal network dysfunction Alzheimers. Dement. 2021 10.1002/alz.12341 34080771 PMC8874214 · DOI · Paper page
  115. [151]McManus RM Higgins SC Mills KHG Lynch MA Respiratory infection promotes T cell infiltration and amyloid-β deposition in APP/PS1 mice Neurobiol. Aging 2014 35 109 121 23993702
  116. [152]Basak JM Bacterial sepsis increases hippocampal fibrillar amyloid plaque load and neuroinflammation in a mouse model of Alzheimer’s disease Neurobiol. Dis. 2021 152 105292 33556539 PMC8057119
  117. [153]Venegas C Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease Nature 2017 552 355 361 29293211
  118. [154]Koffie RM Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques Proc. Natl Acad. Sci. USA 2009 106 4012 4017 19228947 PMC2656196
  119. [155]Torvell M A single systemic inflammatory insult causes acute motor deficits and accelerates disease progression in a mouse model of human tauopathy Alzheimers. Dement. 2019 5 579 591 PMC6804509 31650014
  120. [157]Kitazawa M Oddo S Yamasaki TR Green KN LaFerla FM Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer’s disease J. Neurosci. 2005 25 8843 8853 16192374 PMC6725603
  121. [159]Valero J Mastrella G Neiva I Sánchez S Malva JO Long-term effects of an acute and systemic administration of LPS on adult neurogenesis and spatial memory Front. Neurosci. 2014 8 83 24795557 PMC4001049
  122. [160]Roe AD Staup MA Serrats J Sawchenko PE Rissman RA Lipopolysaccharide-induced tau phosphorylation and kinase activity — modulation, but not mediation, by corticotropin-releasing factor receptors Eur. J. Neurosci. 2011 34 448 456 21722209 PMC3148267
  123. [161]Li Y Liu L Barger SW Griffin WST Interleukin-1 mediates pathological effects of microglia on tau phosphorylation and on synaptophysin synthesis in cortical neurons through a p38–MAPK pathway J. Neurosci. 2003 23 1605 1611 12629164 PMC3833596
  124. [163]Davis DHJ Worsening cognitive impairment and neurodegenerative pathology progressively increase risk for delirium Am. J. Geriatr. Psychiatry 2015 23 403 415 25239680 PMC4278840
  125. [164]Cunningham C Systemic inflammation induces acute behavioral and cognitive changes and accelerates neurodegenerative disease Biol. Psychiatry 2009 65 304 312 18801476 PMC2633437
  126. [165]Hosseini S Michaelsen-Preusse K Schughart K Korte M Long-term consequence of non-neurotropic H3N2 influenza A virus infection for the progression of Alzheimer’s disease symptoms Front. Cell. Neurosci. 2021 15 643650 33994946 PMC8113629
  127. [167]Field R Campion S Warren C Murray C Cunningham C Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNα/β and IL-1β responses in the diseased brain and exacerbates chronic neurodegeneration Brain Behav. Immun. 2010 24 996 1007 20399848 PMC3334265
  128. [168]Hawkins RB Chronic critical illness and the persistent inflammation, immunosuppression, and catabolism syndrome Front. Immunol. 2018 9 1511 30013565 PMC6036179
  129. [170]Arshad A Progression of acute kidney injury to chronic kidney disease in sepsis survivors: 1-year follow-up study J. Intensive Care Med. 2020 36 1366 1370 32878537
  130. [171]White LE Acute kidney injury is surprisingly common and a powerful predictor of mortality in surgical sepsis J. Trauma. Acute Care Surg. 2013 75 432 438 24089113 PMC3823059
  131. [172]Ghaly T Hydrogel-embedded endothelial progenitor cells evade LPS and mitigate endotoxemia Am. J. Physiol. Renal Physiol. 2011 301 F802 F812 21775481 PMC3191807
  132. [173]Andonegui G Characterization of S. pneumoniae pneumonia-induced multiple organ dysfunction syndrome: an experimental mouse model of gram-positive sepsis. Shock 2009 31 423 428 18827750
  133. [174]Bobot M Uremic toxic blood–brain barrier disruption mediated by AhR activation leads to cognitive impairment during experimental renal dysfunction J. Am. Soc. Nephrol. 2020 31 1509 1521 32527975 PMC7350986
  134. [175]Lau WL Chronic kidney disease increases cerebral microbleeds in mouse and man Transl. Stroke Res. 2020 11 122 134 31055735 PMC6957561
  135. [176]Huang C-T Tsai Y-J Tsai P-R Yu C-J Ko W-J Epidemiology and outcome of severe sepsis and septic shock in surgical intensive care units in northern Taiwan Medicine 2015 94 e2136 26632737 PMC5059006
  136. [177]Reade MC Finfer S Sedation and delirium in the intensive care unit N. Engl. J. Med. 2014 370 444 454 24476433
  137. [178]Girard TD Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study Lancet Respir. Med. 2018 6 213 222 29508705 PMC6709878
  138. [179]Schweickert WD Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial Lancet 2009 373 1874 1882 19446324 PMC9906655
  139. [180]Looker KJ Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012 PLoS ONE 2015 10 e0140765 26510007 PMC4624804
  140. [181]Marcocci ME Herpes simplex virus-1 in the brain: the dark side of a sneaky infection Trends Microbiol. 2020 28 808 820 32386801
  141. [182]Cook CH Occult herpes family viral infections are endemic in critically ill surgical patients Crit. Care Med. 2003 31 1923 1929 12847384
  142. [183]Cook CH Trgovcich J Zimmerman PD Zhang Y Sedmak DD Lipopolysaccharide, tumor necrosis factor α, or interleukin-1β triggers reactivation of latent cytomegalovirus in immunocompetent mice J. Virol. 2006 80 9151 9158 16940526 PMC1563908
  143. [185]Doll JR Hoebe K Thompson RL Sawtell NM Resolution of herpes simplex virus reactivation in vivo results in neuronal destruction PLoS Pathog. 2020 16 e1008296 32134994 PMC7058292
  144. [186]Zhou F Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 2020 395 1054 1062 32171076 PMC7270627
  145. [187]Pun BT Prevalence and risk factors for delirium in critically ill patients with COVID-19 (COVID-D): a multicentre cohort study Lancet Respir. Med. 2021 9 239 250 33428871 PMC7832119
  146. [189]Helms J Delirium and encephalopathy in severe COVID-19: a cohort analysis of ICU patients Crit. Care 2020 24 491 32771053 PMC7414289
  147. [190]Lee M-H Microvascular injury in the brains of patients with COVID-19 N. Engl. J. Med. 2021 384 481 483 33378608 PMC7787217
  148. [192]Thakur KT COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital Brain 2021 10.1093/brain/awab148 33856027 PMC8083258 · DOI
  149. [193]Matschke J Neuropathology of patients with COVID-19 in Germany: a post-mortem case series Lancet Neurol. 2020 19 919 929 33031735 PMC7535629
  150. [194]Meinhardt J Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19 Nat. Neurosci. 2021 24 168 175 33257876
  151. [195]Song E Neuroinvasion of SARS-CoV-2 in human and mouse brain J. Exp. Med. 2021 218 e20202135 33433624 PMC7808299
  152. [197]Wang C ApoE-isoform-dependent SARS-CoV-2 neurotropism and cellular response Cell Stem Cell 2021 28 331 342.e5 33450186 PMC7832490
  153. [198]Zheng J COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice Nature 2021 589 603 607 33166988 PMC7855185
  154. [199]Song E Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms Cell Rep. Med. 2021 2 100288 33969321 PMC8091032
  155. [201]Garcia MA Cerebrospinal fluid in COVID-19 neurological complications: neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm J. Neurol. Sci. 2021 427 117517 34090021 PMC8166041
  156. [202]Yang AC Dysregulation of brain and choroid plexus cell types in severe COVID-19 Nature 2021 595 565 571 34153974 PMC8400927
  157. [204]Lucas C Longitudinal analyses reveal immunological misfiring in severe COVID-19 Nature 2020 584 463 469 32717743 PMC7477538
  158. [205]Thwaites RS Inflammatory profiles across the spectrum of disease reveal a distinct role for GM-CSF in severe COVID-19 Sci. Immunol. 2021 6 eabg9873 33692097 PMC8128298
  159. [206]Huang C Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China Lancet 2020 395 497 506 31986264 PMC7159299
  160. [207]Hadjadj J Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients Science 2020 369 718 724 32661059 PMC7402632
  161. [208]Drake TM Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO clinical characterisation protocol UK: a prospective, multicentre cohort study Lancet 2021 398 223 237 34274064 PMC8285118
  162. [210]Zhang S Sepsis-induced selective loss of NMDA receptors modulates hippocampal neuropathology in surviving septic mice PLoS ONE 2017 12 e0188273 29176858 PMC5703474
  163. [211]Chen Z Lipopolysaccharide-induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4 J. Neurosci. 2012 32 11706 11715 22915113 PMC4461442
  164. [212]Chen Z Microglial displacement of inhibitory synapses provides neuroprotection in the adult brain Nat. Commun. 2014 5 4486 25047355 PMC4109015
  165. [213]Kondo S Kohsaka S Okabe S Long-term changes of spine dynamics and microglia after transient peripheral immune response triggered by LPS in vivo Mol. Brain 2011 4 27 21682853 PMC3138393
  166. [214]Chavan SS HMGB1 mediates cognitive impairment in sepsis survivors Mol. Med. 2012 18 930 937 22634723 PMC3459473
  167. [215]Huerta PT Preclinical models of overwhelming sepsis implicate the neural system that encodes contextual fear memory Mol. Med. 2016 22 789 799 27878209 PMC5193462
  168. [216]Blank T Brain endothelial- and epithelial-specific interferon receptor chain 1 drives virus-induced sickness behavior and cognitive impairment Immunity 2016 44 901 912 27096319
  169. [217]Cavaillon J Singer M Skirecki T Sepsis therapies: learning from 30 years of failure of translational research to propose new leads EMBO Mol. Med. 2020 12 e10128 32176432 PMC7136965
  170. [218]Ormerod BK PPARγ activation prevents impairments in spatial memory and neurogenesis following transient illness Brain Behav. Immun. 2013 29 28 38 23108061 PMC3570721
  171. [219]Abraham MN Use of organ dysfunction as a primary outcome variable following cecal ligation and puncture: recommendations for future studies Shock 2020 54 168 182 31764625 PMC7987105
  172. [220]Franchi L Eigenbrod T Núñez G Cutting edge: TNF-α mediates sensitization to ATP and silica via the NLRP3 inflammasome in the absence of microbial stimulation J. Immunol. 2009 183 792 796 19542372 PMC2754237
  173. [221]Bauernfeind FG Cutting edge: NF-κB activating pattern recognition and cytokine receptors license NLRP3 inflammasome activation by regulating NLRP3 expression J. Immunol. 2009 183 787 791 19570822 PMC2824855
  174. [222]Zhu Q Kannegant T-D Distinct regulatory mechanisms control proinflammatory cytokines IL-18 and IL-1β J. Immunol. 2017 198 4210 4215 28468974 PMC5544497
  175. [223]Muñoz-Planillo R K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter Immunity 2013 38 1142 1153 23809161 PMC3730833
  176. [224]Choi HB Ryu JK Kim SU McLarnon JG Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain J. Neurosci. 2007 27 4957 4968 17475804 PMC6672082
  177. [225]Mingam R In vitro and in vivo evidence for a role of the P2X7 receptor in the release of IL-1β in the murine brain Brain Behav. Immun. 2008 22 234 244 17905568 PMC2908086
  178. [227]Harland M Torres S Liu J Wang X Neuronal mitochondria modulation of LPS-induced neuroinflammation J. Neurosci. 2020 40 1756 1765 31937559 PMC7046320
  179. [229]Agostini L NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle–Wells autoinflammatory disorder Immunity 2004 20 319 325 15030775
  180. [230]Thornberry NA A novel heterodimeric cysteine protease is required for interleukin-1β processing in monocytes Nature 1992 356 768 774 1574116
  181. [231]Franklin BS The adaptor ASC has extracellular and ‘prionoid’ activities that propagate inflammation Nat. Immunol. 2014 15 727 737 24952505 PMC4116676

Authors
Manabe, T., & Heneka, M. T.
Affiliations
University of Bonn (DE)
Corresponding author
Heneka, Michael T.
Venue
Nature Reviews Immunology
Published
2021-11-11
Volume
22
Issue
7
Pages
444-458
ISSN
  • 1474-1733 (ISSN-L)
  • 1474-1741
OpenAlex
W3214216551
Cited by
191
References
237
Citations by year
2026: 32 · 2025: 64 · 2024: 37 · 2023: 39 · 2022: 19
FWCI
5.52
Type
journal article
Language
en
Open access
Locations
  • Nature reviews. Immunology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • Open Repository and Bibliography (University of Luxembourg) (submittedVersion)
  • DZNE Pub (submittedVersion)
Funders
Deutsche Forschungsgemeinschaft
Topics
  • Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
  • Health Sciences › Medicine › Epidemiology › Sepsis Diagnosis and Treatment
  • Life Sciences › Immunology and Microbiology › Microbiology › Bacterial Infections and Vaccines
Keywords
sepsis-associated encephalopathy, sepsis, aging, systemic inflammation, neuroinflammation, cognitive impairment, delirium, COVID-19 pandemic, neurodegenerative diseases, sedative side effects, renal dysfunction, latent virus reactivation, neurovascular dysfunction, intensive care
MeSH terms
COVID-19, Aged, Aging, Brain Diseases, Humans, Sepsis, Sepsis-Associated Encephalopathy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review